 SAN DIEGO, Jan. 22, 2023 GLOBE NEWSWIRE The law firm of Robbins Geller Rudman Dowd LLP announces that purchasers of Y-mAbs Therapeutics, Inc. NASDAQ: YMAB common stock on the open market, or pursuant to Registration Statements filed with the U.S. Securities and Exchange Commission SEC, between October 6, 2020 and October 28, 2022, ... The post YMAB INVESTOR NOTICE: Robbins Geller Rudman Dowd Announces that Y-mAbs Therapeutics, Inc. Investors with Substantial Losses Have Opportunity... 